Zhenlong (Hong Kong) Limited ndi  chinthu chovomerezeka chokha cha Jiangsu Lianhuan Pharmaceuticals Co., Ltd. kuti apange malonda mwalamulo kuchokera ku China ndi kugawa zinthu zamankhwala za AOLI m'maiko opitilira 80 padziko lonse.

Zhenlong (Hong Kong) Limited ke sehlopha se etellang pele sa lefats'e la biopharmaceutical se ikhethang ho ntlafatsa bophelo ba batho ka ho kopanya saense, theknoloji, le talenta. Re thabela ho hlahisa mekhahlelo ea rona ea AOLI tadalafil le dapoxetine hydrochloride, pono ea rona ke ho ntlafatsa boleng ba bophelo ka tharollo e ncha ea bongaka.

imikhiqizo

izizwe

 umthamo

+

——

IMIKHI

+

——

IMIKHI

ISIBALO

——

USD INCOME

——

+

Bonnie drives the technical strategy of the flowbite platform and brand.

Imikhiqizo yenkampani ifaka-

izigaba eziyisihlanu ezinkulu zokwelapha:

1. Uhlelo lwezokwelapha lwezitho zangasese

2. Ama-Antihistamines

3. Izinhliziyo

4. AmaHormone eSteroid

5. Ama-Antibiotic

Ikampani ikhule yaba yinkampani yezobuchwepheshe ezingeni eliphezulu kazwelonke ehlanganisa R&D, ukukhiqiza kanye nokumaketha, futhi imikhiqizo yayo ihlanganisa izinsiza eziphilayo, ama-API emithi kanye nezindlela zokuphakelwa kwemithi eziphelile.

Imali engenayo yenkampani iyadlula u-RMB 2 billion.

Lianhuan Pharma has formed two R&D platforms in Nanjingand Yangzhou bas-ed on ac-ademician workstation and d-octor workstation, and has established good technical cooperation relations wi-th Shanghai Institute of Pharmaceutical Research of Chinese Acade-my of Sci-ences and China Pharma-ceutical Uni-versity, etc.

Uhlanga oluphakeme lweqembu le-R&D labantu abangaphezu kwama-150

elihlanganisa abacwaningi abanama-PhD kanye nezidanga ze-masters.

Lianhuan Pharma has formed two R&D platforms in Nanjing and Yangzhou based on academician workstation and doctor workstation.

Ikampani ifake isicelo se-patent ezingaphezu kwama-70 zomdabu nokwakha, futhi ithole ama-patent angama-25.

超过20人从苏北人民医院、市妇幼保健院、市药材公司和百货商店中选出，组成“地方国有扬州制药厂筹备处”

地方国有的扬州制药厂已更名为“中国制药工业公司扬州制药厂”，并由中国制药工业公司南京分公司（信托）管理。

Acetyltestosterone yatholwe umklomelo weJiangsu Province Excellent New Product (Golden Bull Award).

Ibizwa ngokuthi 'Provincial Advanced Enterprise'.

扬州制药厂作为主要发起方，与上海联创投资管理有限公司、中国医药集团制药有限公司及其他企业共同成立了江苏联环制药有限公司。

Ibanga leziwombe selidlulelile ekuhloleni kwe-GMP okwenziwa ezweni, futhi inkampani ithole isitifiketi sayo sokuqala se-GMP.

Ikampani ibhaliswe kuShanghai Stock Exchange (ikhodi yesitoko: 600513), uMongameli uYao Xingtian eshaya igongolo ukuvula imakethe, ekhuphula cishe ama-yuan angama-150 million.

Ikhampani ibonwe njengebhizinisi elihlonipha izivumelwano futhi ethembekile nguHulumeni wesifunda saseJiangsu. I-Aprilet kanye namathebula ayo baziwa njengezimpahla ezintsha ezibalulekile zikaZwelonke nguMnyango Wezesayensi Nezobuchwepheshe, uMnyango Wezohwebo, nezinye izigaba.

Ikampani ibonwe njengeyodwa yeziqhamo eziphezulu eziyi-100 zezimboni zokwelapha eChina nguMnyango Wezokudla Nezidakamizwa "Iindaba Zezimali Zokwelapha".

Ikampani ithole ngokuphelele i-Yangzhou Pharmaceutical Co., Ltd. futhi yakhethwa njengenye yezinkampani eziphezulu eziyi-100 embonini yezokwelapha eChina emhlanganweni wesibili weMisebenzi Yezokwelapha Kazwelonke.

Ikampani ibambe umcimbi wokwakha endaweni yayo entsha yefektri eMphakathini Wezempilo Yezobuchwepheshe eYangzhou National High tech Industrial Development Zone.

我们的客户群遍布东南亚、非洲、南美洲和中东地区。